Bile Duct Cancer
Conditions
Keywords
bile duct, bile duct cancer
Brief summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in bile duct cancer clinical trials, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with bile duct cancer who may be invited to participate in medical research in the years to come.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Signed written informed consent * Patient has been diagnosed with bile duct cancer
Exclusion criteria
* Woman pregnant or susceptible to the being * Inability to perform regular electronic reporting * Inclusion in another investigational clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of bile duct cancer patients who decide to enroll in a clinical study | 3 months |
| Rate of bile duct cancer patients who remain in a clinical study to completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed